Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-13

FDA Approved: LEVETIRACETAM — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for LEVETIRACETAM submitted by NorthStar RxLLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)